RTX (RTX) Upgraded to Buy: Here's Why

RTX was upgraded to Zacks Rank #2 (Buy) after its consensus FY2026 EPS estimate rose 4.4% over the past three months. Analysts expect RTX to earn $7.22 per share in FY2026, unchanged from the year-ago reported level. The upgrade places RTX among the top 20% of Zacks-covered stocks by estimate-revision momentum and suggests modest near-term upside potential.

Analysis

The estimate-revision signal is insufficiently granular to underwrite a new RTX position without identifying whether the change is driven by commercial aftermarket mix, defense program execution, tax/share-count assumptions, or a lower-cost outlook. A modest upward revision can support factor flows over days to weeks, but it does not resolve the larger valuation question: RTX must demonstrate that incremental revenue converts to cash rather than being absorbed by supply-chain remediation, engine-related costs, and working-capital needs.

Near term, RTX could outperform passive defense exposure if revised estimates prompt quant and momentum buying; the more useful relative expression is RTX versus LMT or NOC, whose earnings streams are more directly tied to defense-budget timing. Over 1-3 months, the catalyst is an earnings print that raises free-cash-flow guidance or confirms durable aerospace aftermarket margins. Over 6-18 months, sustained execution would favor RTX suppliers and MRO-adjacent beneficiaries such as HEI and TDG, while a defense procurement slowdown would compress the entire group’s multiple despite intact backlog.

Contrarian view: a mechanical rating change is widely observable and likely low-information after the fact. The market should discount it unless aggregate forward EPS revisions continue upward and management converts them into higher cash guidance; unchanged reported-year EPS versus the prior year implies limited evidence of accelerating earnings power. QBTS has no fundamental linkage to this development and should not be treated as a read-through trade.

Key Decisions for Investors

• Do not chase RTX on the rating-driven open; initiate only after confirming the next-quarter consensus EPS and FCF estimates have risen broadly across major sell-side models. Target a 1-3 month tactical position, with thesis invalidated by unchanged or reduced FCF guidance.
• Preferred relative-value setup: long RTX / short LMT in equal beta-adjusted dollars for 3 months if RTX’s next earnings release shows aerospace-margin or FCF upside. This isolates execution-led estimate momentum from broad defense-sector and rate risk; exit if RTX forward EPS revisions stall for two consecutive weeks.
• For existing RTX exposure, set a catalyst alert around quarterly cash conversion, aftermarket sales growth, and any update on manufacturing/supply-chain costs. A revenue beat without improved cash conversion is a trim signal rather than confirmation.
• Avoid QBTS as a sympathy position; there is no identified customer, supplier, technology, or capital-allocation connection to RTX. Revisit only if independently verified defense-contract or quantum-program evidence emerges.